{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:13:17Z","timestamp":1779923597502,"version":"3.53.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jceh.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:56:25Z","timestamp":1573041385000},"page":"189-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Sofosbuvir\u2013Velpatasvir Fixed Drug Combination for the Treatment of Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease and Kidney Transplantation"],"prefix":"10.1016","volume":"10","author":[{"given":"Nisha","family":"Gaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjai","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Beniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Jhorawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2019.10.004_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Natl Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2019.10.004_bib2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jceh.2019.10.004_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jceh.2014.05.006","article-title":"Consensus statement of HCV task force of the Indian national association for study of the liver (INASL). Part I: status report of HCV infection in India","volume":"4","author":"Puri","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2019.10.004_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0971-4065.53324","article-title":"Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital","volume":"19","author":"Jasuja","year":"2009","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.jceh.2019.10.004_bib5","first-page":"1529","article-title":"Hepatitis C virus infection in dialysis patients: a retrospective study from a tertiary care hospital of North India","volume":"4","author":"Soin","year":"2015","journal-title":"Int J Res Dev Pharm Life Sci"},{"key":"10.1016\/j.jceh.2019.10.004_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"Scott","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2019.10.004_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/ajkd.2001.28576","article-title":"Hepatitis C virus infection and renal transplantation","volume":"38","author":"Fabrizi","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jceh.2019.10.004_bib8","series-title":"Recommendations for Testing, Managing, and Treating Hepatitis C-The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America","year":"2018"},{"key":"10.1016\/j.jceh.2019.10.004_bib9","first-page":"18","volume":"vol. 8","year":"2018"},{"key":"10.1016\/j.jceh.2019.10.004_bib10","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir-velpatasvir in HCV genotype 1, 2, 4, 5, or 6 .(ASTRAL-1)","volume":"373","author":"Feld","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2019.10.004_bib11","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir-velpatasvir in genotype 3 ASTRAL-3 treatment na\u00efve & experienced","volume":"373","author":"Foster","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2019.10.004_bib12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2019.10.004_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5009\/gnl16078","article-title":"Ultrasonography for Noninvasive Assessment of Portal Hypertension","volume":"11","author":"Maruyama","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2019.10.004_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.27366","article-title":"Concordance of sustained virological response 4,12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus","volume":"61","author":"Yoshida","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.10.004_bib15","doi-asserted-by":"crossref","first-page":"483490","DOI":"10.1080\/17425255.2017.1292253","article-title":"Antonio Rivero & Antonio Rivero-Juarez Pharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infection","volume":"13","author":"Brieva","year":"2017","journal-title":"Expert Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.jceh.2019.10.004_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ekir.2017.04.003","article-title":"Hemodialysis patients treated for hepatitis C using a sofosbuvir-based regimen","volume":"2","author":"Agarwal","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jceh.2019.10.004_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2016.02.044","article-title":"Pharmacokinetics, safety and efficacy of a full dose so fosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C","volume":"65","author":"Desnoyer","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.10.004_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2019.05.028","article-title":"Sofosbuvir\/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis","volume":"71","author":"Borgia","year":"2019","journal-title":"J Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688319302713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688319302713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:54Z","timestamp":1760853954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688319302713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0973688319302713"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2019.10.004","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofosbuvir\u2013Velpatasvir Fixed Drug Combination for the Treatment of Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease and Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}